These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 36618187)

  • 1. Telogen effluvium after COVID-19 vaccination among public in Saudi Arabia.
    Alharbi M
    J Family Med Prim Care; 2022 Oct; 11(10):6056-6060. PubMed ID: 36618187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dermoscopy-assisted prevalence of hair loss after COVID-19 vaccination among an Egyptian population: a cross-sectional study.
    Ammar AM; Ibrahim IS; Mohamed AN; Elsaie ML
    Ir J Med Sci; 2024 Apr; 193(2):755-760. PubMed ID: 37580623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19 infection is a major cause of acute telogen effluvium.
    Sharquie KE; Jabbar RI
    Ir J Med Sci; 2022 Aug; 191(4):1677-1681. PubMed ID: 34467470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Telogen effluvium and COVID-19: a cross-sectional study.
    Aldahish A; Vasudevan R; Salem H; Alqahtani A; AlQasim S; Alqhatani A; Al Shahrani M; Al Mohsen L; Hajla M; Calina D; Sharifi-Rad J
    Eur Rev Med Pharmacol Sci; 2023 Aug; 27(16):7823-7830. PubMed ID: 37667959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of Hair Loss After COVID-19 Infection in Makkah Region, Saudi Arabia.
    Abdulwahab RA; Aldajani BM; Natto NK; Janabi AM; Alhijaili OI; Faqih NT; Alharbi A
    Cureus; 2022 Sep; 14(9):e29285. PubMed ID: 36277546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Association Between Hair Loss and COVID-19: The Impact of Hair Loss After COVID-19 Infection on the Quality of Life Among Residents in Saudi Arabia.
    Alkeraye S; Alrashidi A; Alotaibi NS; Almajli N; Alkhalifah B; Bajunaid N; Alharthi R; AlKaff T; Alharbi K
    Cureus; 2022 Oct; 14(10):e30266. PubMed ID: 36381793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trichodynia and telogen effluvium in COVID-19 patients: Results of an international expert opinion survey on diagnosis and management.
    Starace M; Iorizzo M; Sechi A; Alessandrini AM; Carpanese M; Bruni F; Vara G; Apalla Z; Asz-Sigall D; Barruscotti S; Camacho F; Doche I; Estrada BD; Dhurat R; Gavazzoni MF; Grimalt R; Harries M; Ioannidis D; McMichael A; Melo DF; Oliveira R; Ovcharenko Y; Pirmez R; Ramot Y; Rudnicka L; Shapiro J; Silyuk T; Sinclair R; Tosti A; Vano-Galvan S; Piraccini BM
    JAAD Int; 2021 Dec; 5():11-18. PubMed ID: 34368790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A systematic review of acute telogen effluvium, a harrowing post-COVID-19 manifestation.
    Hussain N; Agarwala P; Iqbal K; Omar HMS; Jangid G; Patel V; Rathore SS; Kumari C; Velasquez-Botero F; López GAB; Vishwakarma Y; Nipu AP; Ahmed NK
    J Med Virol; 2022 Apr; 94(4):1391-1401. PubMed ID: 34931698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic Telogen Effluvium: Is it a Distinct Condition? A Systematic Review.
    Daunton A; Harries M; Sinclair R; Paus R; Tosti A; Messenger A
    Am J Clin Dermatol; 2023 Jul; 24(4):513-520. PubMed ID: 37052778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Case Series and Literature Review of Telogen Effluvium and Alopecia Universalis after the Administration of a Heterologous COVID-19 Vaccine Scheme.
    Hernández Arroyo J; Izquierdo-Condoy JS; Ortiz-Prado E
    Vaccines (Basel); 2023 Feb; 11(2):. PubMed ID: 36851320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of patients with telogen effluvium during the pandemic: May the monocytes be responsible for post COVID-19 telogen effluvium?
    Koç Yıldırım S; Erbağcı E; Demirel Öğüt N
    J Cosmet Dermatol; 2022 May; 21(5):1809-1815. PubMed ID: 35201647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of telogen effluvium hair loss in COVID-19 patients and its relationship with disease severity.
    Seyfi S; Alijanpour R; Aryanian Z; Ezoji K; Mahmoudi M
    J Med Life; 2022 May; 15(5):631-634. PubMed ID: 35815081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Post Covid telogen effluvium: the diagnostic value of serum ferritin biomarker and the preventive value of dietary supplements. a case control study.
    Bedair NI; Abdelaziz AS; Abdelrazik FS; El-Kassas M; AbouHadeed MH
    Arch Dermatol Res; 2024 Jun; 316(6):336. PubMed ID: 38844670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of QR678 Neo
    Shome D; Kapoor R; Surana M; Vadera S; Shah R
    J Cosmet Dermatol; 2022 Jan; 21(1):16-23. PubMed ID: 34875139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hair disorders associated with post-COVID-19 infection in females: a cross-sectional study.
    Awad NEHA; Obaid ZM; Zaky MS; Elsaie ML
    Ir J Med Sci; 2024 Apr; 193(2):761-767. PubMed ID: 37704885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Telogen Effluvium: A Review of the Literature.
    Asghar F; Shamim N; Farooque U; Sheikh H; Aqeel R
    Cureus; 2020 May; 12(5):e8320. PubMed ID: 32607303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19 vaccination side effects among the child age group: a large cross-sectional online based survey in Saudi Arabia.
    Alwafi H; Naser AY; Aldhahir AM; Alhazmi A; Alosaimi AN; Mandili RA; Majeed Z; Salawati E; Ekram R; Samannodi M; Assaggaf H; Almatrafi M; Alqahtani JS; Alsanosi SM; Minshawi F
    BMC Infect Dis; 2022 Dec; 22(1):911. PubMed ID: 36474174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19-induced hair shedding and related risk factors: A Saudi perspective.
    Bukhari AE; AlDosari DA; AlDosari MA; Muqrin RF; Moazin OM; Almutlq MM; Altalhab SM; Alharithy RS; Alkhalifah AI
    J Family Med Prim Care; 2023 Dec; 12(12):3304-3311. PubMed ID: 38361868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-SARS-CoV-2 Acute Telogen Effluvium: An Expected Complication.
    Monari P; Gualdi G; Bettoni G; Costa R; Ragni G; Zani F; Bianchi G; Casella S; Casella E; Crippa M; Calzavara Pinton P; Di Nicola M; Porreca A; Amerio P; Guizzi P
    J Clin Med; 2022 Feb; 11(5):. PubMed ID: 35268325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of telogen effluvium in COVID-19 in western Iran (2020).
    Babaei K; Kavoussi H; Rezaei M; Kavoussi R
    An Bras Dermatol; 2021; 96(6):688-692. PubMed ID: 34593265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.